The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists

Abstract

Humans consider themselves discrete autonomous organisms, but recent research is rapidly strengthening the appreciation that associated microorganisms make essential contributions to human health and well-being. Each person is inhabited and also surrounded by his/her own signature microbial cloud. A low diversity of microorganisms is associated with a plethora of diseases including allergy, diabetes, obesity, arthritis, inflammatory bowel diseases and even neuropsychiatric disorders. Thus, an interaction of microorganisms with the host immune system is required for a healthy body. Exposure to microorganisms from the moment we are born and appropriate microbiome assembly during childhood are essential for establishing an active immune system necessary to prevent disease later in life. Exposure to microorganisms educates the immune system, induces adaptive immunity and initiates memory B and T cells that are essential to combat various pathogens. The correct microbial-based education of immune cells may be critical in preventing the development of autoimmune diseases and cancer. This review provides a broad overview of the importance of the host microbiome and accumulating knowledge of how it regulates and maintains a healthy human system.

IL‐1 and IL‐1 regulatory pathways in cancer progression and therapy

“…Colitis‐associated intestinal cancer has served as a paradigm for the connection between inflammation and cancer . Signals originating from microbes and dysbiosis are key drivers of gastrointestinal tumorigenesis . IL‐1 is downstream of microbial sensing by epithelial cells or innate immunity cells.…”

Commensal Fungi in Health and Disease

“…The microbiota influences diverse functions including gut permeability and barrier function, vitamin synthesis, metabolism, neurologic activity, metabolism of pharmaceuticals, and inflammation and immunity (Thomas et al, 2017b). While characterization of microbiota has been hindered in previous decades by limitations in culture methods, targeted and shotgun high-throughput sequencing technologies have more recently revolutionized our understanding of microbial diversity at various body sites.…”

Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive ‘Cold’ Tumors ‘Hot’

“…Recent clinical data indicates that indoximod safely heightens the efficacy of anti-PD1 in melanoma patients [116], consistent with preclinical data [117], suggesting that mTORC1 restoration may be a sufficient cause of the antitumor effects of IDO1 blockade [116]. D-amino acids are used for signaling by gut bacteria and the potential interface of IDO1 with the gut microbiome is intriguing to consider in light of D-Trp and its mimetic indoximod as possible PAMP molecules [118, 119]. Further mechanistic investigations of indoximod might yield important new therapeutic directions.…”